SCHEMBL514930

SCHEMBL514930

CCCCCNc1ncncn1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 2/20 0.46
DNM2 P50570 11/20 0.44
S1PR2 O95136 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HCAR3 P49019 1/20 0.42
KMT2A Q03164 1/20 0.42
CCNB2 O95067 2/20 0.39
CDK1 P06493 2/20 0.39
CCNB1 P14635 2/20 0.39
CCNB3 Q8WWL7 2/20 0.39
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3689386 0.98 DNM2 (0.46) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL11810015 0.98 DNM2 (0.46) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL6519113 0.98 DNM2 (0.46) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL6671613 0.98 DNM2 (0.46) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL30728604 0.98 DNM2 (0.46) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL28859626 0.98 DNM2 (0.46) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL4723163 0.94 HCAR3 (0.41) KCNH3DNM2S1PR2LMNASMN1; SMN2
SCHEMBL29528459 0.88 FAAH (0.45) DNM2S1PR2LMNASMN1; SMN2NPSR1
SCHEMBL4723579 0.85 ALDH1A1 (0.42) LMNASMN1; SMN2HCAR3KMT2AALDH1A1
SCHEMBL516082 0.83 KCNH3 (0.54) KCNH3DNM2S1PR2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354097-B2 Cosmetic composition forming after application a supramolecular polymer L'OREAL (FR) 2013-01-15 US claimed
US-20120027698-A9 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS L'OREAL S.A. 2012-02-02 US claimed
US-7862805-B2 Cosmetic composition forming after application a supramolecular polymer L'OREAL (FR) 2011-01-04 US claimed
US-20100278764-A1 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS L'OREAL S.A. 2010-11-04 US claimed
US-20100242188-A1 COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM L'OREAL S.A. (FR) 2010-09-30 US claimed
US-20100247466-A1 COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER L'OREAL (FR) 2010-09-30 US claimed
EP-2083791-A2 COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM L'Oreal (FR) 2009-08-05 EP claimed
EP-1768644-B1 LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS CIBA HOLDING INC (CH) 2009-02-18 EP claimed
WO-2008059125-A2 COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM L'OREAL (FR) 2008-05-22 WO claimed
US-20070264208-A1 Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process L'OREAL S.A. (FR) 2007-11-15 US claimed
EP-1797868-A1 Cosmetic composition comprising a (thio)urethane/(thio)urea copolymer capable of forming at least 3 hydrogen bonds, and process for cosmetic treatment L'Oréal (FR) 2007-06-20 EP claimed
JP-2006505514-A 2006-02-16 JP claimed
US-20050267109-A1 Pyridyl-triazine derivatives as microbiocidal active substances CIBA SPECIALTY CHEMICALS CORP. 2005-12-01 US claimed
JP-2005520777-A 2005-07-14 JP claimed
EP-1525196-A1 PYRIDYL-TRIAZINE DERIVATIVES AS MICROBICIDAL ACTIVE SUBSTANCES Ciba SC Holding AG (CH) 2005-04-27 EP claimed
US-20040161394-A1 Cosmetic composition forming after application a supramolecular polymer L'OREAL (FR) 2004-08-19 US claimed
EP-1392222-A1 COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER L'OREAL (FR) 2004-03-03 EP claimed
WO-2004013124-A1 PYRIDYL-TRIAZINE DERIVATIVES AS MICROBICIDAL ACTIVE SUBSTANCES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-02-12 WO claimed
WO-2002098377-A1 COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER L'OREAL (FR) 2002-12-12 WO claimed
WO-1995012585-A1 TEXTILE TREATMENT UNIVERSITY OF LEEDS (GB) 1995-05-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070264208-A1 Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process KRT18, DSG1, DSC1 KCNH3 548/4885DNM2 2766/4885S1PR2 3341/4885
US-20100242188-A1 COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM KRT18, S100A6, IK KCNH3 921/4885DNM2 3139/4885S1PR2 4863/4885
US-20120027698-A9 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS KRT18, DSG1, DSC1 KCNH3 574/4885DNM2 2700/4885S1PR2 3321/4885
US-20040161394-A1 Cosmetic composition forming after application a supramolecular polymer KRT18, DSG1, CUTA KCNH3 555/4885DNM2 1079/4885S1PR2 3601/4885
US-20100278764-A1 COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS KRT18, DSG1, DSC1 KCNH3 574/4885DNM2 2700/4885S1PR2 3321/4885
US-20100247466-A1 COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER KRT18, CUTA, DSG1 KCNH3 477/4885DNM2 1019/4885S1PR2 3392/4885
US-20050267109-A1 Pyridyl-triazine derivatives as microbiocidal active substances C3AR1, C1S, C5 KCNH3 992/4885DNM2 2024/4885S1PR2 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.